Sign In
Buy SRDX
$42.98
+0 (+0%)
At Close: Feb 24, 2026
Surmodics (SRDX) Stock Loses 2.2% Despite Q4 Earnings Beat
10:46am, Friday, 12'th Nov 2021
Surmodics' (SRDX) fiscal fourth-quarter results reflect benefits from segmental strength.
Surmodics' (SRDX) CEO Gary Maharaj on Q4 2021 Results - Earnings Call Transcript
01:59pm, Wednesday, 10'th Nov 2021
Surmodics' (SRDX) CEO Gary Maharaj on Q4 2021 Results - Earnings Call Transcript
Surmodics' (SRDX) Latest Sublime Catheter Expands Patient Pool
08:50pm, Tuesday, 05'th Oct 2021
Surmodics' (SRDX) latest addition is expected to aid in performing more complex interventions which were earlier not possible.
Surmodics Announces Successful First Patient Uses of Sublime™ Radial Access .018 RX PTA Dilatation Catheter
08:15am, Wednesday, 29'th Sep 2021
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics Announces Successful First Patient Uses of Sublime™ Radial Access .018 RX PTA Dilatation Catheter
HRC vs. SRDX: Which Stock Is the Better Value Option?
02:46pm, Tuesday, 10'th Aug 2021
HRC vs. SRDX: Which Stock Is the Better Value Option?
Surmodics, Inc. (SRDX) CEO Gary Maharaj on Q3 2021 Results - Earnings Call Transcript
12:37pm, Saturday, 07'th Aug 2021
Surmodics, Inc. (SRDX) CEO Gary Maharaj on Q3 2021 Results - Earnings Call Transcript
Surmodics' (SRDX) Q3 Earnings, Revenues Fall Shy of Estimates
12:10pm, Thursday, 05'th Aug 2021
Higher revenues from the IVD segment drives Surmodics' (SRDX) fiscal third-quarter top line.
SurModics (SRDX) Reports Q3 Loss, Misses Revenue Estimates
10:43am, Wednesday, 04'th Aug 2021
SurModics (SRDX) delivered earnings and revenue surprises of -54.55% and -0.32%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Surmodics Q3 Earnings
07:48am, Wednesday, 04'th Aug 2021
Shares of Surmodics (NASDAQ:SRDX) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share fell 180.95% year over year to ($0.17), which were in line with the es
Surmodics Reports Third Quarter Fiscal 2021 Results and Updates Fiscal 2021 Revenue and EPS Guidance
07:30am, Wednesday, 04'th Aug 2021
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #IVD--Surmodics Reports Third Quarter Fiscal 2021 Results and Updates Fiscal 2021 Revenue and EPS Guidance
Surmodics Announces Successful First Patient Use of Pounce™ Thrombectomy System
08:30am, Thursday, 29'th Jul 2021
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #510K--Surmodics Announces Successful First Patient Use of Pounce™ Thrombectomy System
HRC vs. SRDX: Which Stock Should Value Investors Buy Now?
12:59pm, Monday, 19'th Jul 2021
HRC vs. SRDX: Which Stock Is the Better Value Option?
Surmodics (SRDX) Boosts Portfolio With Vetex Medical Buyout
08:16am, Wednesday, 07'th Jul 2021
Surmodics' (SRDX) buyout of Vetex Medical adds second FDA 510 (k) cleared device to its thrombectomy platform.
Surmodics Builds Thrombectomy Portfolio with Acquisition of Vetex Medical Limited
08:05am, Tuesday, 06'th Jul 2021
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #Acquisition--Surmodics Builds Thrombectomy Portfolio with Acquisition of Vetex Medical Limited
HRC vs. SRDX: Which Stock Is the Better Value Option?
12:47pm, Friday, 02'nd Jul 2021
HRC vs. SRDX: Which Stock Is the Better Value Option?
